Relaxin
Relaxin is a pharmaceutical drug with 9 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
4
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
3
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Relaxin Therapy for Atrial Fibrillation
Progressive Relaxation for COPD: Effects on Insomnia and Satisfaction
Relaxin and Placental Volume in Placenta Accreta Spectrum
Effect of Autogenic Relaxation Therapy on Caregivers on Perceived Stress Quality of Life and Caregiver Burden
A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin
Clinical Trials (9)
Relaxin Therapy for Atrial Fibrillation
Progressive Relaxation for COPD: Effects on Insomnia and Satisfaction
Relaxin and Placental Volume in Placenta Accreta Spectrum
Effect of Autogenic Relaxation Therapy on Caregivers on Perceived Stress Quality of Life and Caregiver Burden
A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin
Efficacy and Safety of Relaxin for the Treatment of Acute Heart Failure
A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart Failure
Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma
Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9